newsfilter
← Latest News
GlobeNewswire·

Tourmaline Bio to Present at Upcoming Investor Conferences

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with